← Back

$ Value

$0

Shares

40,874

Price

$0

Filed

Mar 4

Insider

Name

Berry Lance A

Title

EVP, COO, CFO & Treasurer

CIK

0001478716

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

217,143

Footnotes

Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date. | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Filing Info

Accession No.

0001628280-26-014890

Form Type

4

Issuer CIK

0000784199

Berry Lance A's History

Date Ticker Type Value
2026-03-03 AORT $239K
2026-03-02 AORT $197K
2026-03-02 AORT A $0
2026-02-24 AORT $160K
2026-02-24 AORT A $0
2026-02-23 AORT $187K
2025-05-20 TMCI A $0

Other Insiders at AORT (90d)

Insider Bought Sold Last
Horton Amy
VP, Chief Accounting Officer
$153K 2026-03-03
Mackin James P
President & CEO
$2.5M 2026-03-03
Berry Lance A
EVP, COO, CFO & Treasurer
$783K 2026-03-03
Holloway Jean F
SVP, General Counsel
$744K 2026-03-04
Davis John E
Chief Commercial Officer
$494K 2026-03-03
Stanton Marshall S.
SVP, Clinical & MD Affair
$275K 2026-03-03